BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Safka K, Graham JJ, Roifman I, Zia MI, Wright GA, Balter M, Dick AJ, Connelly KA. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis. J Magn Reson Imaging. 2014;39:609-616. [PMID: 23720077 DOI: 10.1002/jmri.24196] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Crouser ED, Ono C, Tran T, He X, Raman SV. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med 2014;189:109-12. [PMID: 24381994 DOI: 10.1164/rccm.201309-1668LE] [Cited by in F6Publishing: 31] [Reference Citation Analysis]
2 Wicks EC, Menezes LJ, Elliott PM. Improving the diagnostic accuracy for detecting cardiac sarcoidosis. Expert Review of Cardiovascular Therapy 2015;13:223-36. [DOI: 10.1586/14779072.2015.1001367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Quijano-Campos JC, Williams L, Agarwal S, Tweed K, Parker R, Lalvani A, Chiu YD, Dorey K, Devine T, Stoneman V, Toshner M, Thillai M. CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study. BMJ Open Respir Res 2020;7:e000608. [PMID: 33037032 DOI: 10.1136/bmjresp-2020-000608] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ayoub C, Pena E, Ohira H, Dick A, Leung E, Nery PB, Birnie D, Beanlands RSB. Advanced Imaging of Cardiac Sarcoidosis. Curr Cardiol Rep 2015;17. [DOI: 10.1007/s11886-015-0572-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
5 Slart RHJA, Glaudemans AWJM, Lancellotti P, Hyafil F, Blankstein R, Schwartz RG, Jaber WA, Russell R, Gimelli A, Rouzet F, Hacker M, Gheysens O, Plein S, Miller EJ, Dorbala S, Donal E; Document Reading Group. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J Nucl Cardiol 2018;25:298-319. [PMID: 29043557 DOI: 10.1007/s12350-017-1043-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 17.0] [Reference Citation Analysis]
6 Ho JSY, Chilvers ER, Thillai M. Cardiac sarcoidosis - an expert review for the chest physician. Expert Rev Respir Med 2019;13:507-20. [PMID: 30099918 DOI: 10.1080/17476348.2018.1511431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lemay S, Massot M, Philippon F, Belzile D, Turgeon PY, Beaudoin J, Laliberté C, Fortin S, Dion G, Milot J, Trottier M, Gosselin J, Charbonneau É, Birnie DH, Sénéchal M. Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review. CJC Open 2021;3:532-48. [PMID: 34027358 DOI: 10.1016/j.cjco.2020.11.022] [Reference Citation Analysis]
8 Sengupta PP, Kramer CM, Narula J, Dilsizian V. The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update. JACC Cardiovasc Imaging 2017;10:1056-71. [PMID: 28882290 DOI: 10.1016/j.jcmg.2017.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
9 Cha MJ, Seo JW, Oh S, Park EA, Lee SH, Kim MY, Park JY. Indirect pathological indicators for cardiac sarcoidosis on endomyocardial biopsy. J Pathol Transl Med 2020;54:396-410. [PMID: 32717775 DOI: 10.4132/jptm.2020.06.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography. J Card Fail. 2015;21:313-322. [PMID: 25512195 DOI: 10.1016/j.cardfail.2014.12.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
11 Smedema JP, Ainslie G, Crijns HJGM. Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2020;63:271-307. [PMID: 32330463 DOI: 10.1016/j.pcad.2020.03.011] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Boban M, Pesa V, Beck N, Manola S, Zulj M, Rotim A, Vcev A. Supplementary Diagnostic Landmarks of Left Ventricular Non-Compaction on Magnetic Resonance Imaging. Yonsei Med J 2018;59:63-71. [PMID: 29214778 DOI: 10.3349/ymj.2018.59.1.63] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Slart RHJA, Koopmans KP, van Geel PP, Kramer H, Groen HJM, Gan CT, Prakken NHJ, Glaudemans AWJM, Nossent GD. Somatostatin receptor based hybrid imaging in sarcoidosis. Eur J Hybrid Imaging 2017;1:7. [PMID: 29782604 DOI: 10.1186/s41824-017-0014-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
14 Zhang J, Li Y, Xu Q, Xu B, Wang H. Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis. Can Respir J 2018;2018:7457369. [PMID: 30651895 DOI: 10.1155/2018/7457369] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
15 Slart RHJA, Glaudemans AWJM, Lancellotti P, Hyafil F, Blankstein R, Schwartz RG, Jaber WA, Russell R, Gimelli A, Rouzet F, Hacker M, Gheysens O, Plein S, Miller EJ, Dorbala S, Donal E, Sciagra R, Bucerius J, Verberne HJ, Lindner O, Übleis C, Agostini D, Signore A, Edvardsen T, Neglia D, Beanlands RS, Di Carli M, Chareonthaitawee P, Dilsizian V, Soman P, Habib G, Delgado V, Cardim N, Cosyns B, Flachskampf F, Gerber B, Haugaa K, Lombardi M, Masci PG; Writing group:, Document reading group:, EACVI Reviewers: This document was reviewed by members of the EACVI Scientific Documents Committee for 2014–2016 and 2016–2018:. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. European Heart Journal - Cardiovascular Imaging 2017;18:1073-89. [DOI: 10.1093/ehjci/jex146] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 8.2] [Reference Citation Analysis]
16 Amin EN, Closser DR, Crouser ED. Current best practice in the management of pulmonary and systemic sarcoidosis. Ther Adv Respir Dis 2014;8:111-32. [PMID: 25034021 DOI: 10.1177/1753465814537367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
17 Sano M, Satoh H, Suwa K, Saotome M, Urushida T, Katoh H, Hayashi H, Saitoh T. Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy. World J Cardiol 2016; 8(9): 496-503 [PMID: 27721933 DOI: 10.4330/wjc.v8.i9.496] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ricci F, Mantini C, Grigoratos C, Bianco F, Bucciarelli V, Tana C, Mastrodicasa D, Caulo M, Donato Aquaro G, Raffaele Cotroneo A, Gallina S. The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis. Curr Med Imaging Rev 2019;15:10-20. [PMID: 31964322 DOI: 10.2174/1573405614666180522074320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kramer CM. Role of Cardiac MR Imaging in Cardiomyopathies. J Nucl Med 2015;56 Suppl 4:39S-45S. [PMID: 26033902 DOI: 10.2967/jnumed.114.142729] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
20 Chapelon-Abric C, Sene D, Saadoun D, Cluzel P, Vignaux O, Costedoat-Chalumeau N, Piette JC, Cacoub P. Cardiac sarcoidosis: Diagnosis, therapeutic management and prognostic factors. Arch Cardiovasc Dis 2017;110:456-65. [PMID: 28566197 DOI: 10.1016/j.acvd.2016.12.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
21 Masri SC, Bellumkonda L. Sarcoid Heart Disease: an Update on Diagnosis and Management. Curr Cardiol Rep 2020;22:177. [PMID: 33119794 DOI: 10.1007/s11886-020-01429-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Palmucci S, Torrisi SE, Caltabiano DC, Puglisi S, Lentini V, Grassedonio E, Vindigni V, Reggio E, Giuliano R, Micali G, Caltabiano R, Andreula C, Foti PV, Ettorre GC, Walsh SL, Vancheri C. Clinical and radiological features of extra-pulmonary sarcoidosis: a pictorial essay. Insights Imaging. 2016;7:571-587. [PMID: 27222055 DOI: 10.1007/s13244-016-0495-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
23 Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72:3158-3176. [PMID: 30545455 DOI: 10.1016/j.jacc.2018.09.072] [Cited by in Crossref: 373] [Cited by in F6Publishing: 320] [Article Influence: 124.3] [Reference Citation Analysis]